The effect of glutamine and dihydroxyacetone supplementation on food intake, weight gain, and postprandial glycogen synthesis in female Zucker rats

Objective: We sought to test the hypothesis that increasing postprandial hepatic glycogen synthesis rate would decrease food intake and growth rate in obese Zucker rats. Design: Supplements of glutamine, with and without dihydroxyacetone (DHA), which have previously been shown to stimulate hepatic glycogen synthesis, were administered in the diet of obese Zucker rats for periods of 1 and 3 wk. Measurements: Food intake and body weight were monitored throughout the experiments. At the end of the feeding period the rats were fed a test meal and injected with 3H2O to measure in vivo rates of glycogen and lipid synthesis. Final plasma glucose and triacylglycerol and hepatic glycogen content were also determined. Carcass fat and water contents were also measured in the 3-wk study. Results: Dietary glutamine had no effect on food intake, weight gain, or body composition. Addition of DHA caused a reduction in food intake and weight gain and a stimulation of in vivo hepatic glycogen synthesis after 1 wk, but these changes were abolished by the end of 3 wk. Hepatic lipogenesis in vivo was increased by DHA treatment for 1 and 3 wk. Conclusions: Stimulation of hepatic glycogen synthesis by DHA treatment was associated with a reduction in food intake. However, the effect of DHA on glycogen synthesis and food intake disappeared after 3 wk of supplementation. © 2006 Elsevier Inc. All rights reserved.

Aiston S, 2000, DIABETOLOGIA, V43, P589, DOI 10.1007-s001250051348; BAQUET A, 1990, J BIOL CHEM, V265, P955; BAQUET A, 1991, BIOCHEM J, V273, P57; CARMONA A, 1989, ARCH BIOCHEM BIOPHYS, V271, P130, DOI 10.1016-0003-9861(89)90263-4; CHEN KS, 1985, J BIOL CHEM, V260, P4683; Cohen SM, 1998, P NATL ACAD SCI USA, V95, P7385, DOI 10.1073-pnas.95.13.7385; CORTEZ MY, 1991, AM J CLIN NUTR, V53, P847; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007-BF00405082; EMERY PW, 1993, NUTR CANCER, V20, P231; KATZ J, 1976, P NATL ACAD SCI USA, V73, P3433, DOI 10.1073-pnas.73.10.3433; KUWAJIMA M, 1986, J BIOL CHEM, V261, P2632; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172-JCI115997; MCGARRY JD, 1987, ANNU REV NUTR, V7, P51; Obeid OA, 1997, NUTR CANCER, V28, P100; Obeid OA, 2000, INT J OBESITY, V24, P508, DOI 10.1038-sj.ijo.0801189; Obeid OA, 2005, NUTRITION, V21, P224, DOI 10.1016-j.nut.2004.03.026; OBEID OA, 1993, NUTR CANCER, V19, P87; Obeid O. A., 1992, Proceedings of the Nutrition Society, V51, p122A; Opara EC, 1996, J NUTR, V126, P273; Paquot N, 2000, INT J OBESITY, V24, P1297, DOI 10.1038-sj.ijo.0801386; PLOMP PJAM, 1990, EUR J BIOCHEM, V191, P237, DOI 10.1111-j.1432-1033.1990.tb19115.x; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074-jbc.272.44.27758; SCHLIESS F, 2003, INT REV CYTOL, V225, P178; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056-NEJM199001253220403; SPYDEVOLD SO, 1978, EUR J BIOCHEM, V89, P329, DOI 10.1111-j.1432-1033.1978.tb12534.x; Stanko RT, 1996, INT J OBESITY, V20, P925; STANKO RT, 1986, METABOLISM, V35, P182, DOI 10.1016-0026-0495(86)90121-6; STANKO RT, 1992, AM J CLIN NUTR, V55, P771; VANDEWERVE G, 1987, DIABETOLOGIA, V30, P169; ZUCKER LM, 1975, P SOC EXP BIOL MED, V148, P498

2

4

3